Chembio Diagnostics Q3 EPS $(0.22) Misses $(0.17) Estimate, Sales $9.72M Miss $9.91M Estimate

Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.17) by 29.41 percent. This is a 37.5 percent decrease over losses of $(0.16) per share

Benzinga · 11/07/2019 22:32

Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.17) by 29.41 percent. This is a 37.5 percent decrease over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $9.72 million which missed the analyst consensus estimate of $9.91 million by 1.92 percent. This is a 3.66 percent increase over sales of $9.377 million the same period last year.